Dr Una FitzGerald

The overarching research theme is the investigation of the pathological processes occurring during multiple sclerosis (MS). Our current major focus is the progressive phase of MS. This is a stage where, 10-15 years after diagnosis, people with MS experience worsening symptoms, leading to reduced mobility, increased fatigue and disruptions in cognitive functions.  Dr FitzGerald coordinated and was lead PI in an  EU-wide Innovative Training Network Consortium that aimed to develop a new approach to treating progessive MS (2019-2024, Marie-Curie-Sklodovska PMSMatTrain project 813263).  Collaborators in Denmark, Germany, France, Belgium, Italy, Spain and the Czech Republic collaborated with Dr FitzGerald, Prof Abhay Pandit and Dr Nathan Quinlan to train 15 ESRs (13 PhDs) who have become expert researchers in the progressive phase of MS. 

In a Parkinson's disease-focused EU-funded project, also an innovative training network (BrainMatTrain), the group has collaborated with a consortium of early-stage researchers and principal investigators, focused on the development of novel biomaterials-based therapies for Parkinson's disease. In the FitzGerald group, a novel model of prodromal Parkinson's disease has been developed. 

While neuroscience, brain function and neurodegenerative disorders are the primary focus of the FitzGerald group, the researchers are also striving to complete their work in a sustainable way. In November 2019, led by Dr FitzGerald, the CÚRAM lab became the first in Europe to gain 'Green Lab' certification, from 'My Green Lab'. 

Galway Green Labs

MS Research at CÚRAM